首页> 外文期刊>Nature reviews Cancer >Cocrystals of Fluconazole with Aromatic Carboxylic Acids: Competition between Anhydrous and Hydrated Solid Forms
【24h】

Cocrystals of Fluconazole with Aromatic Carboxylic Acids: Competition between Anhydrous and Hydrated Solid Forms

机译:氟康唑与芳香羧酸的碳酸酯:无水和水合固体形式之间的竞争

获取原文
获取原文并翻译 | 示例
       

摘要

Through cocrystallization of the broad-spectrum antifungal agent fluconazole (FLZ) with a number of nutraceuticals, we have isolated three distinct solid forms of the drug, namely, anhydrous cocrystal with vanillic acid (VA) and anhydrous and hydrated cocrystals of 4-hydroxybenzoic acid (4OHBA). The new cocrystals have been thoroughly investigated by different analytical techniques, including powder and single crystal X-ray diffractometry (XRD), differential scanning calorimetry (DSC), thermogravimetric analysis (TG), scanning electron microscopy (SEM), and dissolution and solubility methods. Analysis of hydrogen bond patterns in the crystals has shown structural similarity in the packing of FLZ molecules between the new crystal forms and the structures taken from the CSD. Comparing the theoretical lattice energies of multicomponent crystals and their constituents, we have found that hydrated crystal forms are more energetically preferable than the anhydrous cocrystals. Analysis of noncovalent interaction energies performed within the framework of quantum theory of atoms in molecules and crystals (QTAIMC) has confirmed the structure-forming role of water molecules in the hydrated cocrystal of FLZ with 4OHBA. Thermal analysis and SEM investigations have shown that the dehydration behavior of FLZ monohydrate (FLZ center dot H2O) is highly sensitive to particle size and morphology of crystals. The pH-solubility behavior of the cocrystals has been investigated at different pH values using eutectic concentrations of the components, and the driving force of the cocrystal formation process for each solid phase has been estimated. Possible cocrystallization pathways between FLZ and 4OHBA have been examined under mechanochemical conditions. A two-step formation mechanism of cocrystallization reaction, which includes generation of an anhydrous [FLZ+4OHBA] (1:1) cocrystal as an intermediate, has been proposed.
机译:通过使用多种营养品的广谱抗真菌剂氟康唑(FLZ)的共聚化,我们已经分离出三种不同的固体形式的药物,即与香草酸(Va)的无水Cocrystal和4-羟基苯甲酸的无水和水合的甲烯酮。 (4ohba)。新共结晶具有由不同的分析技术,包括粉末和单晶X射线衍射法(XRD),差示扫描量热法(DSC),热重分析(TG),扫描电子显微镜(SEM),和溶解和溶解度的方法被彻底调查。分析晶体中的氢键图案在新晶体形式与来自CSD中取出的结构之间的填充物中的结构相似性。比较多组分晶体及其成分的理论晶格能量,我们发现水合晶体形式比无水钴晶体更具能量。在分子和晶体(QTAIMC)原子的量子论的框架内进行的非共价相互作用能量的分析已确认的水分子在FLZ与4OHBA水合共晶体结构形成的作用。热分析和SEM研究表明,FLZ单水合物(FLZ中心点H2O)的脱水行为对粒度和晶体形态的高度敏感。已经在不同的pH值中研究了通过组分的不同pH值研究了Cocrystals的pH-溶解度行为,并且已经估计了每个固相的Cocrystal形成方法的驱动力。在机械化学条件下检查了FLZ和4OHBA之间可能的聚碳化途径。已经提出了一种双步形成机理,包括产生无水[Flz + 4Ohba](1:1)作为中间体的含量的产生。

著录项

  • 来源
    《Nature reviews Cancer》 |2020年第2期|共11页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

  • 入库时间 2022-08-19 17:30:32

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号